Intravenous Solutions Market Expected to Reach $18.95 billion by 2028
Overview
The intravenous solutions market has experienced significant growth in recent years, from $12.9 billion in revenue in 2023 to $14 billion in 2024, representing an 8.6% compound annual growth rate (CAGR). This growth is largely due to an increase in surgical procedures, a growing prevalence of chronic diseases, expansion of home healthcare, stringent safety regulations, and a heightened focus on patient hydration. The market is projected to continue its strong growth trajectory, reaching $18.95 billion by 2028 with a CAGR of 7.9%.
Market Drivers
The factors driving this expansion include population growth, aging demographics, increasing surgical interventions, rising incidence of infectious diseases, advancements in telemedicine and remote patient monitoring, emphasis on preventive healthcare, global health security investments, and trends towards patient-centric care.
Major Players and Market Trends
Key players in the intravenous solutions market, including Pfizer Inc., Abbott Laboratories, and Fresenius SE & Co. KGaA, are focusing on innovation in product development, particularly in pre-filled and ready-to-administer syringes. These innovations aim to enhance convenience, reduce medication errors, and improve patient outcomes.
GENIXUS Corp. launched KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer syringes, featuring RFID technology and intuitive design elements for enhanced safety and efficiency.
Market Segments
Product Types:
- Total Parenteral Nutrition
- Peripheral Parenteral Nutrition
Nutrients:
- Carbohydrates
- Vitamins And Minerals
- Single Dose Amino Acids
- Parenteral Lipid Emulsion
- Other Nutrients
Applications:
- Basic Intravenous (IV) Solution
- Nutritional Intravenous (IV) Solution
- Blood Intravenous (IV) Solution
- Drug Intravenous (IV) Solution
- Irrigation Intravenous (IV) Solution
End Users:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Home Care Settings
Regional Insights
North America dominated the intravenous solutions market in 2023, with Asia-Pacific expected to exhibit the fastest growth during the forecast period.
Conclusion
The Intravenous Solutions Global Market Report 2024 by The Business Research Company provides in-depth insights into the intravenous solutions market size and trends, major players, competitors’ revenues, market positioning, and growth potential across geographies. Healthcare companies can use this market intelligence to identify opportunities and develop winning strategies in this fast-growing market.
Originally Post From https://tech.einnews.com/pr_news/722966349/intravenous-solutions-market-size-share-revenue-trends-and-drivers-for-2024-2033
